Dr Girish Shantilal Achliya, Director of NovaPharm Healthcare
Director & Chief Scientific Officer

Dr Girish Shantilal Achliya

Dr Girish supports scientific strategy, product development, technical due diligence and the development of a differentiated oncology and specialty portfolio.

Statutory director; executive title described in the March 2026 business plan
Executive profile

Responsibilities grounded in NovaPharm's operating plan.

Dr Girish brings more than 25 years of pharmaceutical research and development experience described in NovaPharm's business-plan materials.

His experience spans formulation and analytical development, intellectual property, clinical and regulatory programmes, technology transfer and external development partnerships. At NovaPharm, he contributes scientific scrutiny to product opportunities, manufacturer assessment and development strategy.

No patent count, product approval or commercial achievement is attributed to Dr Girish on this website unless it is separately verified and approved for publication.

View Companies House appointment
Start a qualified conversation

Discuss a qualified pharmaceutical partnership.